• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Life Science Market
    Life Science News
    Life Science Stocks
    • Life Science Market
    • Life Science News
    • Life Science Stocks

    More Patients Surviving Ebola in Sierra Leone

    Written by Charlotte McLeod
    |
    Dec. 24, 2014 11:29AM PST

    The Associated Press reported that although the Ebola outbreak is still raging, around 70 percent of patients in one of Sierra Leone’s hard-hit areas now survive.

    The Associated Press reported that although the Ebola outbreak is still raging, around 70 percent of patients in one of Sierra Leone’s hard-hit areas now survive. Interestingly, there are still no specific medicines or vaccines to fight the virus.

    As quoted in the market news:

    In a letter published online Wednesday by the New England Journal of Medicine, Dr. Kathryn Jacobsen of George Mason University in Fairfax, Virginia, and other doctors tell of 581 patients taken to an Ebola treatment centre that opened near Sierra Leone’s capital, Freetown, in late September.

    They were given antibiotics, malaria medicines, ibuprofen for pain and fever, intravenous nutrients, anti-nausea medicine and other supportive care. About 31 per cent died, including 38 people who were dead when they arrived. Among those admitted more recently, since Nov. 5, mortality was less than 24 per cent.

    That is much lower than the 74 per cent death rate other doctors reported for 106 patients who were treated in the eastern Sierra Leone town of Kenema, in May and June, when some health workers were on strike and response to the outbreak was in crisis mode.

    Click here to read the full report from The Associated Press.

    The Conversation (0)

    Go Deeper

    AI Powered

    Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial

    Ebola Outbreak Hurting West Africa’s Iron Ore Companies

    Latest News

    BriaCell Announces ESMO 2026 Poster Highlighting Circulating Immune Biomarker Associated with Clinical Outcomes in Metastatic Breast Cancer

    Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule

    BPH Energy Limited September 2026 Quarter Operations Report

    Quarterly Activities/Appendix 4C Cash Flow Report

    Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Life Science Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES